Macy's Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Macy's Inc trades at $24.17 (market cap $6.45B), while State Street SPDR S&P Biotech ETF trades at $159.4. The key difference: Macy's Inc pays a 3.12% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| M | XBI | |
|---|---|---|
Market Cap | $6.45B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $26.21 | $164.28 |
52-Week Low | $12.73 | $86.92 |
Enterprise Value | $10.26B | — |
Dividend Yield | 3.12% | — |
Signals from Pluang's Aura AI — not financial advice
Macy's (M) trades at $24.9, down 1.97% on the day, with a bullish technical signal and strong earnings beat history. The company shows improving fundamentals with net income margin recovery to 2.94% and positive cash flow trends. Recent institutional buying and analyst coverage reflects growing confidence in the turnaround strategy, though revenue declines remain a concern.
The stock presents value opportunity with attractive valuation multiples (P/E 10.13, P/S 0.3) and dividend yield. Upside potential exists to the $30 analyst target, but risks include ongoing revenue pressure and competitive retail environment. The successful execution of 'Bold New Chapter' strategy remains critical for sustained recovery.
No Aura AI signal available yet.
Trailing returns across standard periods
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →